I doubt it very much but this sort of conference is very positive and important as companies look to expand the use of TAVR and it's market.
Admedus will be a strong beneficiary of this market expansion.
Ann: Appendix 3B - ESOP, page-199
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.85 |
Change
-0.150(0.83%) |
Mkt cap ! $348.1M | |||
| Open | High | Low | Value | Volume |
| $18.00 | $18.11 | $17.80 | $48.97K | 2.733K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 41 | $17.65 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $17.85 | 5 | 1 |
View Market Depth
| Last trade - 15.37pm 08/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |